脳
鏀惰棌-鍋ュ悍緗戜細鍛樿闂褰?/h3>
| 緗戦〉鏍囬錛? | |
脳
娉ㄥ唽鍋ュ悍緗戠敤鎴?/h3>
| 鐢?鎴?鍚嶏細 | ||
|---|---|---|
| 鑱?緋?浜猴細 | 鎬?nbsp; 鍒細 | |
| 瀵?nbsp; 鐮侊細 | ||
| 閲嶅瀵嗙爜錛?/th> | ||
| 鐢靛瓙閭錛?/th> | ||
| 閭楠岃瘉鐮侊細 | ||
| 鍥哄畾鐢佃瘽錛?/th> | ||
| 浼?nbsp; 鐪燂細 | ||
| 鎵?nbsp; 鏈猴細 | ||
| 鍗曚綅鍚嶇О錛?/th> | ||
| 閫氫俊鍦板潃錛?/th> | ||
| 棣栭夋爮鐩細 | ||
| 鎴戝凡緇忚鐪熼槄璇誨茍鍚屾剰銆婂仴搴風綉鏈嶅姟鏉℃銆?/a> | ||
| 紜畾娉ㄥ唽 | ||
鎮ㄧ幇鍦ㄤ綅緗細鍋ュ悍緗?鍖昏嵂浜т笟 >> 鍥介檯鑽笟 >> 鍥介檯浼佷笟 >> 浼佷笟鍔ㄦ?/a> >> 嫻忚鍥介檯鑽笟
紺兼潵涓庣編鍥芥斂搴滅緗?3浜跨編鍏僀OVID-19鎶椾綋渚涘簲鍗忚
浣滆咃細鏈煡 鏉ユ簮錛氫簰鑱旂綉 鐐瑰嚮鏁幫細0 鏇存柊鏃墮棿錛?021-11-5 16:31:01
鐩稿叧榪炴帴
鏈楂?.25 浜跨編鍏冿細紺兼潵涓嶵elix Pharmaceuticals灝眔laratumab 杈炬垚璁稿彲鍗忚
紺兼潵1.65浜跨編鍏冪爺鍙戞敹璐氦鏄撻伃緹庡浗SEC璐ㄧ枒
Japans First! The Recombinant Protein COVID-19 Vaccine Introduced by Takeda Has Been Approved For Marketing
The $100 billion COVID-19 drug market
5 Chinese Pharmaceutical Companies Authorized to Produce Key Ingredients of Pfizers COVID-19 Oral Drug
紺兼潵闆瘋帿瑗垮挨鍗曟姉鍦ㄥ浗鍐呰幏鎵逛笂甯?/a>
瀵筄micron鏈夋晥錛岀ぜ鏉ユ柊鍐犳姉浣揃ebtelovimab鑾稦DA绱фヤ嬌鐢ㄦ巿鏉?/a>
NMPA闄勬潯浠舵壒鍑嗚緣鐟炲彛鏈嶆柊鍐犵梾姣掓不鐤楄嵂鐗?/a>
紺兼潵1.65浜跨編鍏冪爺鍙戞敹璐氦鏄撻伃緹庡浗SEC璐ㄧ枒
Japans First! The Recombinant Protein COVID-19 Vaccine Introduced by Takeda Has Been Approved For Marketing
The $100 billion COVID-19 drug market
5 Chinese Pharmaceutical Companies Authorized to Produce Key Ingredients of Pfizers COVID-19 Oral Drug
紺兼潵闆瘋帿瑗垮挨鍗曟姉鍦ㄥ浗鍐呰幏鎵逛笂甯?/a>
瀵筄micron鏈夋晥錛岀ぜ鏉ユ柊鍐犳姉浣揃ebtelovimab鑾稦DA绱фヤ嬌鐢ㄦ巿鏉?/a>
NMPA闄勬潯浠舵壒鍑嗚緣鐟炲彛鏈嶆柊鍐犵梾姣掓不鐤楄嵂鐗?/a>